找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive license to

[復(fù)制鏈接]
樓主: 選民
21#
發(fā)表于 2025-3-25 04:16:48 | 只看該作者
22#
發(fā)表于 2025-3-25 11:25:21 | 只看該作者
Abdulrazzak Zarifa,Juan Lopez-Mattei,Nicolas L. Palaskas,Cezar Iliescu,Jean-Bernard Durand,Peter Y. tinued to be the case despite recent advances in the treatment of acute events, which have proven to decrease disability and improve outcomes. Over recent years, there has been significant growth in the field of acute stroke care and stroke systems of care. This includes improvements in the manageme
23#
發(fā)表于 2025-3-25 14:22:34 | 只看該作者
24#
發(fā)表于 2025-3-25 17:57:31 | 只看該作者
25#
發(fā)表于 2025-3-25 23:54:47 | 只看該作者
Immunotherapy for Melanoma,n, we provide an overview of the results of recent advances in the adjuvant setting for patients with resected stage III and stage IV melanoma, as well as in patients with melanoma brain metastases. Finally, we provide a brief overview of the current research efforts in the field of immuno-oncology for melanoma.
26#
發(fā)表于 2025-3-26 00:16:11 | 只看該作者
27#
發(fā)表于 2025-3-26 07:50:37 | 只看該作者
Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity,toxicities related to immunotherapy are reportedly rare, they can be severe and associated with life-threatening conditions such as fulminant myocarditis, hemodynamic instability, and cardiac arrest. We will review the most commonly reported cardiovascular toxicities associated with ICIs and their management.
28#
發(fā)表于 2025-3-26 08:36:35 | 只看該作者
29#
發(fā)表于 2025-3-26 13:16:06 | 只看該作者
Resistance to Immunotherapy: Mechanisms and Means for Overcoming,rucial to understand the pathophysiology of the tumor-immune system interplay and the mechanisms of immune escape in order to circumvent primary and acquired resistance. Here we provide an outline of the most well-defined mechanisms of resistance and shed light on ongoing efforts to reinvigorate immunoreactivity.
30#
發(fā)表于 2025-3-26 16:49:46 | 只看該作者
Renal Toxicity, autoimmune disease with a focus on renal cell cancer in setting of chronic kidney disease (CKD). Transplant rejection in setting of CPI use has been further evaluated with single-center and multicenter retrospective studies, and available data will be presented in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
开江县| 孟津县| 简阳市| 全南县| 奉节县| 东丽区| 玉树县| 瑞金市| 武强县| 璧山县| 姜堰市| 清水县| 定陶县| 镇赉县| 罗平县| 扎兰屯市| 西丰县| 临沧市| 鄂托克前旗| 双鸭山市| 屏边| 桓台县| 大城县| 南澳县| 乌苏市| 廉江市| 靖州| 建平县| 仙游县| 兴海县| 安丘市| 平原县| 万盛区| 毕节市| 徐州市| 乐都县| 溧阳市| 霍城县| 贵州省| 扎囊县| 宜良县|